What elephant ?
We get it . Itʼs something no one wants to talk about . It takes up half the room and no one says a word . How smart is it to invest in an industry as new as ours ?
How smart to invest in a company in the same business as three-dozen other companies doing the same thing ? Short answer : it isnʼt . Which is why at GB Sciences weʼre not doing the same thing .
And we may be the elephant in the room , but weʼre tickled pink when people start to notice . About the GB Sciences elephant : Our cultivation process has given us higher yields per active flower light than any other major grower in the Nevada market . Call that the trunk . A trunk whose revenue feeds our constantly expanding cultivation capacity . Not exactly peanuts .
Our proprietary tissue propagation process minimizes genetic drift the way an elephantʼs foot minimizes a ping pong ball .
Speaking of feet , weʼve got ours planted firmly in Nevada , with plans to
gbsciences the future of healing
OTCQB : GBLX www . gbsciences . com trek across California , Texas and Louisiana . Our sturdy legs will carry us into the biggest markets in the US , where thereʼs plenty of green to feed the beast .
And what about those big ears of ours ? Well , theyʼre always listening . To science . Weʼre the only cannabis company in the US to partner with a major research university , LSU Agcenter , to explore the plant and commercialize tissue propagation . Now thatʼs a jumbo sized business opportunity . And weʼre starting in-human patient studies for our Parkinsonʼs formulations this year . Of course , our big brains help a lot there .
So , go ahead , talk all you want about the elephant in the room .
Then hop on and come along for the ride .
This elephant has a lot of room left to cover .